Literature DB >> 24464849

A screening tool for clinically relevant urinary incontinence.

Anne M Suskind1, Rodney L Dunn, Daniel M Morgan, John O L DeLancey, Karl T Rew, John T Wei.   

Abstract

AIMS: The Michigan Incontinence Symptom Index (M-ISI) is a validated measure for urinary incontinence. This study evaluates the M-ISI as a screening tool for clinically relevant urinary incontinence in a population-based sample of women.
METHODS: The Establishing the Prevalence of Incontinence (EPI) Study is a case-control, population-based study that enrolled women ages 35-64, with and without urinary incontinence. The M-ISI is a validated questionnaire with subdomains for stress and urgency urinary incontinence. Two hundred fourteen EPI subjects underwent a clinical evaluation and urodynamic testing to establish the presence and type of urinary incontinence, and also completed the M-ISI. The M-ISI scores were evaluated using receiver operating characteristic (ROC) curves to determine the optimal diagnostic threshold scores above which women were likely to have clinically relevant urinary incontinence.
RESULTS: The optimal M-ISI diagnostic threshold scores were determined to be ≥ 3 for the stress urinary incontinence subdomain (area under the curve of 0.79), ≥ 5 for the urgency urinary incontinence subdomain (area under the curve of 0.88), and ≥ 7 for the Total M-ISI score (area under the curve of 0.89). The sensitivity and specificity of the M-ISI questionnaire for stress, urgency, and total urinary incontinence were 77% and 73%, 86% and 76%, and 84% and 75%, respectively.
CONCLUSIONS: The M-ISI may be used to screen for clinically relevant urinary incontinence with high sensitivity and specificity among women ages 35-64. A brief, self-administered tool such as the M-ISI can help health care providers identify and manage women with urinary incontinence.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  population; quality of life; receiver operating characteristic curve; screening; sensitivity; specificity; validation

Mesh:

Year:  2014        PMID: 24464849      PMCID: PMC4111784          DOI: 10.1002/nau.22564

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  21 in total

1.  Distress and delay associated with urinary incontinence, frequency, and urgency in women.

Authors:  P A Norton; L D MacDonald; P M Sedgwick; S L Stanton
Journal:  BMJ       Date:  1988-11-05

2.  Urinary incontinence. GPs lack confidence.

Authors:  J V Jolleys; J V Wilson
Journal:  BMJ       Date:  1993-05-15

Review 3.  Female urinary incontinence--the role of the general practitioner.

Authors:  A Seim; S Hunskaar
Journal:  Acta Obstet Gynecol Scand       Date:  2000-12       Impact factor: 3.636

4.  A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests.

Authors:  H Sandvik; A Seim; A Vanvik; S Hunskaar
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

5.  A new questionnaire for urinary incontinence diagnosis in women: development and testing.

Authors:  Catherine S Bradley; Eric S Rovner; Mark A Morgan; Michelle Berlin; Joseph M Novi; Judy A Shea; Lily A Arya
Journal:  Am J Obstet Gynecol       Date:  2005-01       Impact factor: 8.661

6.  The development and evaluation of an incontinence screening questionnaire for female primary care.

Authors:  W Gunthorpe; W Brown; S Redman
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

7.  The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence.

Authors:  Jeanette S Brown; Catherine S Bradley; Leslee L Subak; Holly E Richter; Stephen R Kraus; Linda Brubaker; Feng Lin; Eric Vittinghoff; Deborah Grady
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

8.  Overactive bladder symptoms: do we need urodynamics?

Authors:  G Alessandro Digesu; Vik Khullar; Linda Cardozo; Stefano Salvatore
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

9.  Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity.

Authors:  H Sandvik; S Hunskaar; A Vanvik; H Bratt; A Seim; R Hermstad
Journal:  J Clin Epidemiol       Date:  1995-03       Impact factor: 6.437

Review 10.  Screening, early detection, and treatment of prostate cancer: a European view.

Authors:  F H Schröder
Journal:  Urology       Date:  1995-09       Impact factor: 2.649

View more
  4 in total

Review 1.  Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.

Authors:  W Timothy Garvey; Jeffrey I Mechanick
Journal:  Obesity (Silver Spring)       Date:  2020-03       Impact factor: 5.002

2.  Women's Urological Health as a Priority to the Woman Well Visit.

Authors:  Elizabeth R Mueller; Margot S Damaser; Monica P Mallampalli; Liliana Losada
Journal:  Womens Health Issues       Date:  2016 Jul-Aug

3.  Quality of life outcomes in peri-urethral calcium hydroxylapatite injection.

Authors:  Meghan A Griffin; Kirsten J C Janosek-Albright; Mireya Diaz-Insua; Solafa Elshatanoufy; Humphrey O Atiemo
Journal:  Int Urogynecol J       Date:  2016-06-01       Impact factor: 2.894

4.  Adaptation and validation of the Michigan Incontinence Severity Index in a Turkish population.

Authors:  Mehmet Akif Sargın; Murat Yassa; Bilge Dogan Taymur; Emrah Ergun; Gizem Akca; Niyazi Tug
Journal:  Patient Prefer Adherence       Date:  2016-05-26       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.